Skip to content

Agilent Technologies A Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$5.24B+84.4%
Danaher logo
DanaherDHR
$0-100%
WAT
Waters CorporationWAT
$3.53B
Bruker logo
BrukerBRKR
$0-100%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$0
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$1.8B+10.0%
Gross profit$990.0M+14.3%
Operating income$399.0M+33.0%
Net income$339.0M+57.7%
EPS (diluted)$1.20+60.0%

Balance sheet

See full
Cash & equivalents$1.8B+21.5%
Total debt$3.5B-3.9%
Total equity$7.1B+16.1%
Total assets$13.1B+7.5%

Cash flow

See full
Operating cash flow$277.0M+25.3%
CapEx$76.0M-33.3%
Free cash flow$201.0M+87.9%

Valuation

See full
Market cap$37.52B+8.8%
Enterprise value$39.25B+7.0%
P/E26.5×-3.0×
P/S5.2×0.0×

Profitability

See full
Gross margin52.7%-0.6pp
Operating margin21.5%+0.1pp
Net margin19.6%+2.0pp
FCF margin15%-2.9pp

Returns & leverage

See full
Return on equity21.3%+2.4pp
Debt / equity0.5×-0.1×
Current ratio2.1×0.0×

Where this comes from

Reported directly by Agilent Technologies in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The official record: Agilent Technologies’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilent Technologies's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilent Technologies's debt issuance proceeds?
Agilent Technologies (A) reported debt issuance proceeds of $0 in Q1 2026.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.